Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Equipment

Capstone Therapeutics Corp

+ Add to Watchlist

CAPS:US

0.2150 USD 0.0010 0.46%

As of 20:10:06 ET on 01/27/2015.

Snapshot for Capstone Therapeutics Corp (CAPS)

Open: 0.2150 Day's Range: 0.2150 - 0.2150 Volume: 406
Previous Close: 0.2160 52wk Range: 0.1850 - 0.3900 1-Yr Rtn: -36.76%

Stock Chart for CAPS

No chart data available.
  • CAPS:US 0.2150
  • 1D
  • 1M
  • 1Y
0.2160
Interactive CAPS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CAPS

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.1000
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 8.79
Shares Outstanding (M) 40.89
30 Day Average Volume 7,745
Price/Book (mrq) 2.4269
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CAPS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CAPS

Capstone Therapeutics Corporation is a biotechnology company that develops therapeutic peptides. The Company researches treatments for pulmonary disease, prevention of hypertrophic and keloid scarring and intimal hyperplasia, and cellular events leading to angiogenesis, revascularization, and repair of dermal and musculoskeletal tissues.

John M Holliman III "Jock"ChairmanLeslie M TaegerSenior VP/CFO
More Company Profile & Key Executives for CAPS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil